RMTI
Rockwell Medical Inc.
$0.64
-$0.01(-1.61%)
41
Overall
60
Value
18
Tech
47
Quality
Market Cap
$26.73M
Volume
223.52K
52W Range
$0.60 - $2.10
Target Price
$3.00
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $53.3M | $57.3M | $63.4M | $61.3M | $62.2M | $61.9M | $72.8M | $83.6M | $101.5M | $69.3M | ||
| Total Revenue | $53.3M | $57.3M | $63.4M | $61.3M | $62.2M | $61.9M | $72.8M | $83.6M | $101.5M | $69.3M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $46.5M | $53.6M | $65.0M | $58.5M | $59.5M | $64.4M | $68.7M | $74.9M | $84.0M | $57.6M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $6.8M | $3.7M | $-1.6M | $-58.5M | $2.7M | $-2.4M | $4.1M | $8.7M | $17.5M | $11.7M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $27.0M | $29.6M | $29.8M | $36.9M | $31.2M | $27.9M | $20.9M | $15.4M | $16.9M | $16.4M | ||
| Research & Development | $5.8M | $6.3M | $6.7M | $6.9M | $7.1M | $6.8M | $3.1M | $1.1M | $19.0K | -- | ||
| Research Expense | $5.8M | $6.3M | $6.7M | $6.9M | $7.1M | $6.8M | $3.1M | $1.1M | $19.0K | -- | ||
| Selling, General & Administrative | $21.1M | $23.3M | $23.1M | $30.0M | $24.1M | $21.1M | $17.7M | $14.3M | $16.9M | $16.4M | ||
| Selling & Marketing Expenses | $21.1M | $23.3M | $1.0M | $9.1M | $7.9M | $5.7M | $2.1M | $2.1M | $2.7M | $2.4M | ||
| General & Administrative Expenses | $-2.4M | $-2.5M | $22.1M | $21.0M | $16.2M | $15.3M | $15.6M | $12.1M | $14.1M | $14.0M | ||
| Salaries & Wages | -- | $-7.2M | $-4.4M | $-5.0M | -- | -- | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-601.1K | $-514.0K | $-649.8K | $-788.0K | $834.0K | $668.0K | $600.0K | $1.2M | $1.6M | -- | ||
| Depreciation & Amortization | $-601.1K | $-514.0K | $-649.8K | $-788.0K | $834.0K | $668.0K | $600.0K | -- | -- | -- | ||
| Amortization | -- | -- | -- | -- | $918.0K | $1.2M | $565.0K | $1.5M | $1.5M | -- | ||
| Other Operating Expenses | -- | -- | -- | $-2.1M | $2.1M | $2.6M | $2.9M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-20.2M | $-83.2M | $-94.8M | $-95.4M | $-28.4M | $-30.3M | $-16.8M | $-6.7M | $608.0K | $-4.7M | ||
| EBITDA | $-18.6M | $-25.4M | $-31.4M | $-31.4M | $-26.7M | $-27.8M | $-16.2M | $-1.6M | $3.4M | $-1.7M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | $25.0K | $1.9M | $2.4M | $1.9M | $2.3M | $1.3M | $1.1M | ||
| Intinc | -- | -- | -- | $392.0K | $238.0K | $22.0K | $33.0K | $211.0K | $92.0K | -- | ||
| Net Non-Operating Interest Income/Expense | $810.3K | $892 | -- | $367.0K | $-1.6M | $-2.3M | $-1.9M | $-147.0K | $-1.3M | $-1.1M | ||
| Gain on Sale of Securities | $183.3K | $65.9K | $-222.3K | $30.0K | $8.0K | -- | $4.0K | $532.0K | $166.0K | $501.0K | ||
| Other Income/Expense | $-183.3K | $-56.5M | $-63.2M | $-61.3M | $829.0K | $-1.9M | $4.0K | $-532.0K | $-166.0K | $-501.0K | ||
| Other Special Charges | $810.3K | $56.5M | $63.4M | $61.3M | $-837.0K | $1.9M | $2.5M | -- | -- | -- | ||
| SPECIAL ITEMS | ||||||||||||
| Special Income Charges | -- | -- | $-1.0M | $-400.0K | -- | -- | -- | $284.0K | $1.0M | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-19.4M | $-25.9M | $-32.1M | $-34.1M | $-29.0M | $-30.3M | $-16.7M | $-6.1M | $768.0K | $-4.3M | ||
| Pre-Tax Income | $-19.4M | $-25.9M | $-32.1M | $-34.1M | $-30.9M | $-32.6M | $-18.7M | $-8.4M | $-480.0K | $-5.3M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $404.5K | -- | -- | -- | -- | -- | -- | -- | $-6.0K | $-69.0K | ||
| NET INCOME | ||||||||||||
| Net Income | $-19.8M | $-25.9M | $-32.1M | $-34.1M | $-30.9M | $-32.7M | $-18.7M | $-8.4M | $-480.0K | $-5.3M | ||
| Net Income (Continuing Operations) | $-19.8M | $-25.9M | $-32.1M | $-34.1M | $-30.9M | $-32.7M | $-18.7M | $-8.4M | $-480.0K | $-5.3M | ||
| Net Income (Discontinued Operations) | $-19.8M | $-25.9M | $-32.1M | $-34.1M | $-30.9M | $-32.7M | $-18.7M | $-8.4M | $-480.0K | $-5.3M | ||
| Net Income (Common Stockholders) | $-19.8M | $-25.9M | $-32.1M | $-34.1M | $-30.9M | $-32.7M | $-18.7M | $-8.6M | $-480.0K | $-5.3M | ||
| Normalized Income | -- | -- | -- | -- | -- | $-25.8M | -- | -- | -- | $-5.4M | ||
| TOTALS | ||||||||||||
| Total Expenses | $19.6M | $24.0M | $35.2M | $95.4M | $90.6M | $92.2M | $89.6M | $90.3M | $100.9M | $73.9M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $4.6M | $4.6M | $4.8M | $5.5M | $6.9M | $8.5M | $9.9M | $23.3M | $31.1M | $36.0M | ||
| Average Shares Outstanding (Diluted) | $4.6M | $4.6M | $4.8M | $5.5M | $6.9M | $8.5M | $9.9M | $23.3M | $31.1M | $36.0M | ||
| Shares Outstanding | $4.7M | $4.7M | $5.2M | $6.3M | $8.5M | $8.5M | $12.6M | $29.3M | $34.1M | $39.4M | ||
| Basic EPS | $-4.29 | $-5.61 | -- | -- | $-4.51 | $-3.85 | $-1.89 | $-0.37 | $-0.03 | $-0.15 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | $-4.51 | $-3.85 | $-1.89 | $-0.37 | $-0.03 | $-0.15 | ||
| Diluted EPS | $-4.29 | $-5.61 | $-6.71 | $-6.16 | $-4.51 | $-3.85 | $-1.89 | $-0.37 | $-0.03 | $-0.15 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $-6.16 | -- | $-3.85 | $-1.89 | $-0.37 | $-0.03 | $-0.15 | ||
| OTHER METRICS | ||||||||||||
| Net Operating Interest Income Expense | -- | $790.2K | $535.6K | -- | -- | -- | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | -- | -- | $1.0M | $400.0K | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $-2.4M | $-2.5M | $22.1M | $21.0M | $16.2M | $15.3M | $15.6M | $12.1M | $14.1M | $14.0M | ||
| Preferred Stock Dividends | -- | -- | -- | -- | -- | -- | -- | $150.0K | $302.0K | -- | ||
| Rent And Landing Fees | $-2.4M | $-2.5M | $22.1M | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $21.1M | $23.3M | $1.0M | $9.1M | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RMTI | $0.64 | -1.6% | 223.52K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |